Book Closure

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE61.02-2.8 (-4.39 %)
PREV CLOSE ( ) 63.82
OPEN PRICE ( ) 63.82
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5026
TODAY'S LOW / HIGH ( )60.63 64.00
52 WK LOW / HIGH ( )51.1 93.2
NSE61.45-2.05 (-3.23 %)
PREV CLOSE( ) 63.50
OPEN PRICE ( ) 63.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 61.45 (198)
VOLUME 39300
TODAY'S LOW / HIGH( ) 60.35 65.00
52 WK LOW / HIGH ( )50.65 93.95

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.